133 related articles for article (PubMed ID: 8979144)
1. Coagulopathy of childhood nephrotic syndrome--a reappraisal of the role of natural anticoagulants and fibrinolysis.
al-Mugeiren MM; Gader AM; al-Rasheed SA; Bahakim HM; al-Momen AK; al-Salloum A
Haemostasis; 1996; 26(6):304-10. PubMed ID: 8979144
[TBL] [Abstract][Full Text] [Related]
2. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
Wygledowska G; Grygalewicz J; Matuszewska E
Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
[TBL] [Abstract][Full Text] [Related]
3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
4. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
5. Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.
Alwakeel J; Gader AM; Hurieb S; al-Momen AK; Mitwalli A; Abu Aisha H
Int Urol Nephrol; 1996; 28(2):255-61. PubMed ID: 8836799
[TBL] [Abstract][Full Text] [Related]
6. Significant elevation of protein C and protein S levels in thrombotic disorders by low dose danazol.
al-Momen AK; Gader AM; Shamena AR; Daif AK; Ajarim D
Blood Coagul Fibrinolysis; 1991 Aug; 2(4):495-9. PubMed ID: 1837483
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
8. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
[TBL] [Abstract][Full Text] [Related]
9. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
10. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome.
Yoshida Y; Shiiki H; Iwano M; Uyama H; Hamano K; Nishino T; Dohi K
Nephron; 2001 May; 88(1):24-9. PubMed ID: 11340346
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic measurements in childhood nephrotic syndrome.
Elidrissy AT; Abdurrahman MB; Bahakim HM; Jones MD; Gader AM
Eur J Pediatr; 1991 Mar; 150(5):374-8. PubMed ID: 2044614
[TBL] [Abstract][Full Text] [Related]
13. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
15. A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndrome.
Gandrille S; Jouvin MH; Toulon P; Remy P; Fiessinger JN; Roncato M; Moatti N; Aiach M
Thromb Haemost; 1988 Jun; 59(3):445-50. PubMed ID: 3142081
[TBL] [Abstract][Full Text] [Related]
16. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
17. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
[TBL] [Abstract][Full Text] [Related]
18. [Haemostatic and fibrinolytic variables in women with anorexia nervosa].
Sobieszczańska S; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(4):741-59. PubMed ID: 16237979
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease.
Tousoulis D; Antoniades C; Tountas C; Bosinakou E; Kotsopoulou M; Toutouzas P; Stefanadis C
Diabetes Care; 2003 Oct; 26(10):2749-53. PubMed ID: 14514574
[TBL] [Abstract][Full Text] [Related]
20. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
Tkaczyk M; Owczarek D; Finke D; Nowicki M
Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
